You just read:

Talecris Biotherapeutics Receives EU Orphan Drug Designation for Plasmin (Human) as a Treatment for Acute Peripheral Arterial Occlusion

News provided by

Talecris Biotherapeutics, Inc.

Mar 03, 2011, 02:35 EST